New experimental drug slows down growth of ovarian cancer
April 16th, 2011 - 3:56 pm ICT by ANIWashington, April 16 (ANI): A new study has found that an experimental drug that blocks two points of a crucial cancer cell signalling pathway inhibits the growth of ovarian cancer cells.
The study at UCLA’s Jonsson Comprehensive Cancer Center performed on mouse models also showed significant increase of survival in mice with ovarian cancer.
The drug, called NVP-BEZ235, also inhibits growth of ovarian cancer cells that have become resistant to the conventional treatment with platinum chemotherapy, and helps to re-sensitize the cancer cells to the therapy.
It also enhances the effect of platinum chemotherapy on ovarian cancer cells that are still responding to the therapy, said Oliver Dorigo, an assistant professor of obstetrics and gynecology and senior author of the study.
Dorigo focused his research on a pathway called PI3Kinase/Akt/mTOR, which once activated promotes ovarian cancer growth.
The activated pathway also makes the cancer more aggressive and more likely to spread to other organs, so targeting it offers great promise for more effective therapies for the disease, according to him.
The study has been published in the April 15, 2011 issue of the journal Clinical Cancer Research. (ANI)
- New drug shows promise against platinum resistant ovarian cancer - Oct 10, 2010
- Novel therapy may eradicate lung cancer - Oct 30, 2009
- Potential new target for treatment of ovarian cancer identified - Aug 17, 2010
- How ovarian cancer resists chemotherapy - Mar 03, 2011
- Scientists uncover pathway that affects breast cancer stem cells' growth - Jun 02, 2009
- New path discovered for colon cancer drug discovery - Nov 20, 2010
- Gene makes ovarian cancer resistant to chemotherapy - Mar 03, 2011
- New discovery opens up novel strategy for combating malaria - Mar 09, 2011
- Cancer drugs may help battle parasite Leishmania - Jul 17, 2010
- New way of treating lung cancer soon - Oct 11, 2011
- Cancer drugs offer new hope for Crohn's disease and sarcoidosis - Dec 01, 2010
- Blue light could be highly in potent platinum-based cancer treatment - Dec 10, 2010
- New genetic signatures of breast cancer drug resistance identified - Jan 11, 2011
- Broccoli and brussels sprouts boost sunscreens' cancer fighting abilities - Apr 27, 2011
- New discovery may help in the fight against ovarian cancer - Feb 04, 2011
Tags: assistant professor, cancer cell, cancer growth, chemotherapy, clinical cancer research, comprehensive cancer center, conventional treatment, dorigo, experimental drug, mice, mouse models, mtor, obstetrics, organs, ovarian cancer, ovarian cancer cells, pathway, platinum, survival, ucla